bioRxivGenomicsPreprint
Motif-based model of transcription predicts effects of sequence variants in AR enhancers and reveals distinct functions for AR-associated transcription factors
Hoda TaebiD, Amin SafaeesiratiD, Emirhan TekogluiD, Kevin Xiao, Chia-Chi Flora HuangiD, Nathan A. LackiD, Eldon G. EmberlyiD
Abstract
Androgen receptor (AR)-mediated transcription plays a central role in prostate cancer development and progression, yet the contributions of individual transcription factors (TFs) to AR-dependent enhancer activity remain incompletely understood. Here we use a biophysically motivated, interpretable motif-based model to dissect these contributions from STARR-seq data in LNCaP cells. By fitting the model separately to androgen inducibility and to baseline enhancer activity, we resolve TFs into three functional classes: hormone-dependent drivers, constitutive activators, and dual-role factors that contribute to both. These patterns suggest that inducibility is associated not only with the presence of AR and co-activator motifs, but also with the relative absence of constitutive activators that may saturate enhancer output. We validate the model against an independent saturation-mutagenesis dataset spanning 40 AR enhancers, predicting mutational effects at single-base resolution (AUC = 0.76), and show that direct fitting to these data independently recovers known AR regulators. Finally, we apply the model to prostate cancer GWAS risk alleles in AR binding site regions, prioritizing four candidate variants predicted to reduce the DHT/EtOH enhancer activity ratio at these loci.
- organism: human
- assay: ATAC-seq
- assay: DNA methylation
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional mapping of androgen receptor enhancer activity
C.-C. F. Huang, S. Lingadahalli, … N. A. Lack·bioRxiv·Aug 18, 2020
- Canonical AREs are tumor suppressive regulatory elements in the prostate
M. A. Augello, X. Chen, … C. Barbieri·bioRxiv·Feb 23, 2024
- HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers
Viacheslav M. Morozov, Alberto Riva, … Alexander M. Ishov·Nucleic Acids ResearchPeer-reviewed·Aug 15, 2023
- Androgen receptor binding sites are highly mutated in prostate cancer
T. MOROVA, M. GÖNEN, … N. A. LACK·Oncology AbstractsPeer-reviewed·Sep 26, 2019
- Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer
L. Poluben, M. Nouri, … S. Balk·bioRxiv·Jan 10, 2024
- NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis
A. Parolia, S. Eyunni, … I. A. Asangani·Nature GeneticsPeer-reviewed·Sep 9, 2024